KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.30 $2.47 Friday, 26th Apr 2024 AKBA stock ended at $1.34. This is 0.752% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.25% from a day low at $1.30 to a day high of $1.35.
90 days $1.30 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jul 12, 2022 $0.420 $0.454 $0.402 $0.450 5 519 696
Jul 11, 2022 $0.460 $0.460 $0.420 $0.420 5 345 769
Jul 08, 2022 $0.439 $0.468 $0.433 $0.460 6 103 847
Jul 07, 2022 $0.450 $0.459 $0.432 $0.451 7 268 445
Jul 06, 2022 $0.390 $0.462 $0.390 $0.460 12 882 409
Jul 05, 2022 $0.388 $0.425 $0.378 $0.409 16 216 309
Jul 01, 2022 $0.494 $0.495 $0.376 $0.389 74 315 155
Jun 30, 2022 $0.345 $0.361 $0.340 $0.353 24 682 362
Jun 29, 2022 $0.460 $0.514 $0.360 $0.380 84 320 752
Jun 28, 2022 $0.370 $0.380 $0.346 $0.350 3 716 188
Jun 27, 2022 $0.367 $0.381 $0.340 $0.374 5 343 154
Jun 24, 2022 $0.400 $0.411 $0.362 $0.365 24 016 776
Jun 23, 2022 $0.355 $0.396 $0.351 $0.393 7 831 990
Jun 22, 2022 $0.335 $0.375 $0.330 $0.356 7 100 082
Jun 21, 2022 $0.345 $0.356 $0.323 $0.345 9 162 362
Jun 17, 2022 $0.319 $0.360 $0.312 $0.342 21 186 574
Jun 16, 2022 $0.341 $0.347 $0.300 $0.321 18 237 173
Jun 15, 2022 $0.390 $0.404 $0.335 $0.353 24 566 034
Jun 14, 2022 $0.379 $0.379 $0.335 $0.354 4 009 232
Jun 13, 2022 $0.390 $0.395 $0.361 $0.367 6 034 907
Jun 10, 2022 $0.421 $0.430 $0.393 $0.408 6 104 490
Jun 09, 2022 $0.445 $0.459 $0.421 $0.442 5 356 145
Jun 08, 2022 $0.430 $0.460 $0.420 $0.445 6 526 940
Jun 07, 2022 $0.372 $0.440 $0.370 $0.429 10 546 468
Jun 06, 2022 $0.409 $0.419 $0.363 $0.382 9 875 577
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT